These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38904370)

  • 21. Evaluation of whole-genome sequence to predict drug resistance of nine anti-
    Che Y; Lin Y; Yang T; Chen T; Sang G; Chen Q; He T
    Front Public Health; 2022; 10():956171. PubMed ID: 36062095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-tuberculous drugs.
    Phelan JE; O'Sullivan DM; Machado D; Ramos J; Oppong YEA; Campino S; O'Grady J; McNerney R; Hibberd ML; Viveiros M; Huggett JF; Clark TG
    Genome Med; 2019 Jun; 11(1):41. PubMed ID: 31234910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissecting whole-genome sequencing-based online tools for predicting resistance in Mycobacterium tuberculosis: can we use them for clinical decision guidance?
    Macedo R; Nunes A; Portugal I; Duarte S; Vieira L; Gomes JP
    Tuberculosis (Edinb); 2018 May; 110():44-51. PubMed ID: 29779772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole-genome sequencing of
    Wang L; Yang J; Chen L; Wang W; Yu F; Xiong H
    Epidemiol Infect; 2022 Jan; 150():e22. PubMed ID: 35086603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-resistance to isoniazid and second-line anti-tuberculosis drugs in isoniazid-resistant tuberculosis at a tertiary care hospital in Thailand.
    Prommi A; Wongjarit K; Petsong S; Somsukpiroh U; Faksri K; Kawkitinarong K; Payungporn S; Rotcheewaphan S
    Microbiol Spectr; 2024 Mar; 12(3):e0346223. PubMed ID: 38323824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of drug susceptibility profile of Mycobacterium tuberculosis Lineage 1 from Brazil based on whole genome sequencing and phenotypic methods.
    Guimarães AEDS; Sharma A; Furlaneto IP; Rutaihwa L; Cardoso JF; da Conceição ML; Spinassé LB; Machado E; Lopes ML; Duarte RS; Gagneux S; Suffys PN; Lima KVB; Conceição EC
    Mem Inst Oswaldo Cruz; 2021; 115():e200520. PubMed ID: 33533871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole-genome sequence analysis and comparisons between drug-resistance mutations and minimum inhibitory concentrations of Mycobacterium tuberculosis isolates causing M/XDR-TB.
    Nonghanphithak D; Kaewprasert O; Chaiyachat P; Reechaipichitkul W; Chaiprasert A; Faksri K
    PLoS One; 2020; 15(12):e0244829. PubMed ID: 33382836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overcoming the pitfalls of automatic interpretation of whole genome sequencing data by online tools for the prediction of pyrazinamide resistance in Mycobacterium tuberculosis.
    Iwamoto T; Murase Y; Yoshida S; Aono A; Kuroda M; Sekizuka T; Yamashita A; Kato K; Takii T; Arikawa K; Kato S; Mitarai S
    PLoS One; 2019; 14(2):e0212798. PubMed ID: 30817803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of drug resistance profile of multidrug-resistant Mycobacterium tuberculosis (MDR-MTB) isolates from newly diagnosed case by whole genome sequencing (WGS): a study from a high tuberculosis burden country.
    Sun W; Gui X; Wu Z; Zhang Y; Yan L
    BMC Infect Dis; 2022 May; 22(1):499. PubMed ID: 35624432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis.
    Heyckendorf J; Andres S; Köser CU; Olaru ID; Schön T; Sturegård E; Beckert P; Schleusener V; Kohl TA; Hillemann D; Moradigaravand D; Parkhill J; Peacock SJ; Niemann S; Lange C; Merker M
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of Whole-Genome Sequencing to Predict
    Wu X; Tan G; Sha W; Liu H; Yang J; Guo Y; Shen X; Wu Z; Shen H; Yu F
    Microbiol Spectr; 2022 Apr; 10(2):e0251621. PubMed ID: 35311541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycobacterium tuberculosis resistance prediction and lineage classification from genome sequencing: comparison of automated analysis tools.
    Schleusener V; Köser CU; Beckert P; Niemann S; Feuerriegel S
    Sci Rep; 2017 Apr; 7():46327. PubMed ID: 28425484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A precision overview of genomic resistance screening in Ecuadorian isolates of Mycobacterium tuberculosis using web-based bioinformatics tools.
    Morey-León G; Mejía-Ponce PM; Granda Pardo JC; Muñoz-Mawyin K; Fernández-Cadena JC; García-Moreira E; Andrade-Molina D; Licona-Cassani C; Berná L
    PLoS One; 2023; 18(12):e0294670. PubMed ID: 38051742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diversified lineages and drug-resistance profiles of clinical isolates of
    Noorizhab Fakhruzzaman MN; Abidin NZ; Aziz ZA; Lim WF; Richard JJ; Noorliza MN; Hani MH; Norhayati R; Zamzurina AB; Farida Zuraina MY; Hisyam MJ; Teh LK; Norazmi MN; Zaki MS
    Int J Mycobacteriol; 2019; 8(4):320-328. PubMed ID: 31793500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-Resistant Characteristics, Genetic Diversity, and Transmission Dynamics of Rifampicin-Resistant Mycobacterium tuberculosis in Hunan, China, Revealed by Whole-Genome Sequencing.
    He W; Tan Y; Liu C; Wang Y; He P; Song Z; Liu D; Zheng H; Ma A; Zhao B; Ou X; Xia H; Wang S; Zhao Y
    Microbiol Spectr; 2022 Feb; 10(1):e0154321. PubMed ID: 35171016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole Genome Sequencing of Mycobacterium tuberculosis under routine conditions in a high-burden area of multidrug-resistant tuberculosis in Peru.
    Puyén ZM; Santos-Lázaro D; Vigo AN; Cotrina VV; Ruiz-Nizama N; Alarcón MJ; Asto B; Huamán T; Moore DAJ
    PLoS One; 2024; 19(6):e0304130. PubMed ID: 38861531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole genome sequencing of Mycobacterium tuberculosis isolates and clinical outcomes of patients treated for multidrug-resistant tuberculosis in Tanzania.
    Katale BZ; Mbelele PM; Lema NA; Campino S; Mshana SE; Rweyemamu MM; Phelan JE; Keyyu JD; Majigo M; Mbugi EV; Dockrell HM; Clark TG; Matee MI; Mpagama S
    BMC Genomics; 2020 Feb; 21(1):174. PubMed ID: 32085703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and Assessment of a Novel Whole-Gene-Based Targeted Next-Generation Sequencing Assay for Detecting the Susceptibility of Mycobacterium tuberculosis to 14 Drugs.
    Wu SH; Xiao YX; Hsiao HC; Jou R
    Microbiol Spectr; 2022 Dec; 10(6):e0260522. PubMed ID: 36255328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-Genome Sequencing for Resistance Level Prediction in Multidrug-Resistant Tuberculosis.
    Li J; Yang T; Hong C; Yang Z; Wu L; Gao Q; Yang H; Tan W
    Microbiol Spectr; 2022 Jun; 10(3):e0271421. PubMed ID: 35658579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.